Product
Synbiotic Supplement
1 clinical trial
2 indications
Indication
SchizophreniaIndication
Schizoaffective DisorderClinical trial
A Double-Blind Placebo-Controlled Trial of the Synbiotic Compound Probio-Tec ABCG for Schizophrenia Patients With and Without Elevated Markers of Gastrointestinal InflammationStatus: Recruiting, Estimated PCD: 2024-09-01